BARCELONA—For children with intracranial ependymoma and measurable residue after first- or second-line surgery, a hypofractionated radiotherapy boost was feasible and improved local control—in a study presented to the 3rd ESTRO Forum. Lead author Lorenza Gandola MD, from Istituto Nazionale dei Tumori in Milan, explained to Oncology Times reporter Sarah Maxwell how they found that increasing the dose of radiotherapy significantly improved survival.
You may also like...
Low Dose Rate Prostate Brachytherapy Doubled Cancer-Free Survival: ASCENDE-RT Study Finding 28 Apr, 2015
Malaria Elimination: Research Findings At ASTMH Conference 2 Jan, 2012
Pelvic Radiotherapy Brought No Benefit in High-Risk Localized Prostate Cancer: GETUG 12 Trial 9 May, 2015
Adjuvant Chemotherapy Extends Life in Locally Advanced Bladder Cancer 13 Mar, 2015
- Previous story Accelerated Partial Breast Irradiation for Women over 70 with Early Breast Cancer Improved Outcomes
- Next story Higher Radiation Dose Improved Survival in Children with Ependymoma
- First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
- Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
- Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
- MMR vaccine’s non-specific effects: adherence to recommended vaccination schedules protects children against non-vaccination-specific infections tooFebruary 28, 2014
- First enterovirus 71 vaccines effective against hand, foot and mouth diseaseFebruary 28, 2014